Goodwin has advised Gilde Healthcare on the financing of the acquisition of MEG Medical Equipment GmbH ("MEG").
MEG is well positioned to enter new market segments and expand into adjacent application areas. In partnership with Gilde Healthcare, MEG will accelerate its growth – both organically and through acquisitions.
MEG combines the two companies Funke Medical and Deron, both providers of high quality medical aids for the prevention and treatment of decubitus in outpatient and homecare settings. Production takes place at two locations in Raesfeld, in North Rhine-Westphalia, Germany. MEG serves an international customer base in Europe and abroad.
Gilde Healthcare is a thematic investment firm managing over €2.6 billion across two fund strategies in healthcare: Private Equity and Venture&Growth. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medical technologies (MedTech) and therapeutics, based in Europe and North America.
Goodwin's transaction team was led by partnerWinfried Carliand associateDaniel Wagnerand included associatePhilipp Lehleand transaction lawyerRina Omura(allPrivate Equity/Finance,Munich) as well as associatePhilipp Lauer(Tax,Munich).